Log In
Print this Print this

HGT 3010

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionNot disclosed
Molecular Target
Mechanism of ActionEnzyme replacement therapy
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPreclinical
Standard IndicationMucopolysaccharidosis
Indication DetailsTreat mucopolysaccharidosis IIIB (MPS IIIB, Sanfilippo type B syndrome)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today